Genetic Variants and Protective Immunity Against SARS-CoV-2

December 2022 in “ Genes ”

Ali A. Rabaan, Abbas Al Mutair, Mohammed Aljeldah, Basim R. Al Shammari, Tarek Sulaiman, Abeer N. Alshukairi, Mubarak Alfaresi, Jumana M. Al-Jishi, Neda A. Al Bati, Maha Al-Mozaini, Ali Al Bshabshe, Jenan Al‐Matouq, Abdulmonem A. Abuzaid, Amal H. Alfaraj, Wasl Al-Adsani, Mohammed Alabdullah, Sara Alwarthan, Fatimah Alsalman, Ameen S. S. Alwashmi, Saad Alhumaid

Studysummary This review discusses the host genetic factors influencing COVID-19 susceptibility and pathogenesis, highlighting genetic variations that affect viral entry and immune responses, but reports no new experimental results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

1 / 1 results

Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

research Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

71 citations , April 2020 in “Journal of Cosmetic Dermatology”

This article discusses the potential link between genetic variants associated with androgen receptor activity and racial variations in COVID-19 mortality, suggesting a possible role for anti-androgens in treatment, but reports no new clinical findings.